Cytek Biosciences Inc (CTKB) — Cash Flow Quality Index
Cytek Biosciences Inc (CTKB) has a Cash Flow Quality Index of 0.21x as of December 2024. Operating cash flow of $2.00 Million is below net income of $9.64 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Cytek Biosciences Inc (CTKB) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cytek Biosciences Inc Cash Flow Quality Index (2020–2022)
Historical Cash Flow Quality Index for Cytek Biosciences Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Cytek Biosciences Inc generate cash.
Annual Cash Flow Quality Index for Cytek Biosciences Inc (2020–2022)
Year-by-year earnings quality comparison for Cytek Biosciences Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -4.92x | $-12.23 Million | $2.48 Million | ▼ -421.9% |
| 2021 | 1.53x | $4.63 Million | $3.03 Million | ▲ +95.9% |
| 2020 | 0.78x | $15.16 Million | $19.41 Million | — |